71 lines
3.3 KiB
Mathematica
71 lines
3.3 KiB
Mathematica
DVBCWSM1 ;ALB/CMM RESPIRATORY, MISC. DISEASES WKS TEXT - 1 ;7 Oct 2000
|
|
;;2.7;AMIE;**34**;Apr 10, 1995
|
|
;
|
|
;
|
|
TXT ;
|
|
;;A. Review of Medical Records:
|
|
;;
|
|
;;B. Medical History (Subjective Complaints):
|
|
;; Comment on:
|
|
;;
|
|
;; 1. Fever and/or night sweats.
|
|
;; 2. Weight loss or gain.
|
|
;; 3. Daytime hypersomnolence.
|
|
;; 4. Hemoptysis.
|
|
;; 5. Describe current treatment such as anticoagulant, tracheostomy, CPAP,
|
|
;; oxygen, or antimicrobial therapy.
|
|
;; 6. If malignant disease, state initial treatment date, site of original
|
|
;; tumor, type of tumor, types of treatment used, and date treatment is
|
|
;; expected to end. If treatment has been completed, state date treatment
|
|
;; was completed.
|
|
;;
|
|
;;C. Physical Examination (Objective Findings):
|
|
;; Address each of the following as appropriate to the condition being
|
|
;; examined and fully describe current findings:
|
|
;;
|
|
;; 1. Pulmonary Hypertension, RVH, cor pulmonale, or congestive heart failure.
|
|
;; 2. Residuals of pulmonary embolism.
|
|
;; 3. Respiratory Failure.
|
|
;; 4. Evidence of chronic pulmonary thromboembolism.
|
|
;; 5. If ankylosing spondylitis, is there restriction of the chest excursion
|
|
;; and dyspnea on minimal exertion?
|
|
;; 6. Describe all residuals of malignancy including those due to treatment.
|
|
;;
|
|
;;D. Diagnostic and Clinical Tests:
|
|
;;
|
|
;;1. Pulmonary Function Tests, if indicated. The FEV-1,FVC, and FEV-1/FVC should
|
|
;; be included. Both pre- and post-bronchodilatation pulmonary function
|
|
;; test results should be reported. If post-bronchodilatation testing is not
|
|
;; conducted in a particular case, please provide an explanation of why not.
|
|
;; A DLCO may or may not be done routinely as part of pulmonary function
|
|
;; testing at a particular facility. If there is a disparity between the results
|
|
;; of different tests, please indicate which tests are more likely to
|
|
;; accurately reflect the severity of the condition.
|
|
;;
|
|
;;TOF
|
|
;; DLCO note: If the DLCO was not done as a routine part of pulmonary
|
|
;; function testing, the examiner should use his or her judgment, based on
|
|
;; the specific condition (e.g., whether it is obstructive, interstitial,
|
|
;; etc.) and other available information about the condition, as to whether
|
|
;; a DLCO test is needed. If it may provide useful information about the
|
|
;; severity of the condition, it should be requested and reviewed before
|
|
;; the examination report is submitted. If the examiner determines that
|
|
;; the DLCO test is not needed, a statement as to why not (e.g., there are
|
|
;; decreased lung volumes that would not yield valid test results) should be
|
|
;; included in the report. Such a statement could avoid a remand from BVA when
|
|
;; the test is not done. However, in the case of BVA remand in which DLCO
|
|
;; is requested, the DLCO MUST be done unless there is a medical
|
|
;; contraindication.
|
|
;;
|
|
;; 2. If sleep apnea is suspected, order Sleep Studies.
|
|
;; 3. Chest X-ray if necessary to document sarcoidosis or other parenchymal
|
|
;; disease.
|
|
;; 4. Include results of all diagnostic and clinical tests conducted in
|
|
;; the examination report.
|
|
;;
|
|
;;E. Diagnosis:
|
|
;;
|
|
;;
|
|
;;Signature: Date:
|
|
;;END
|